Market revenue in 2020 | USD 309.1 million |
Market revenue in 2028 | USD 589.2 million |
Growth rate | 8.4% (CAGR from 2020 to 2028) |
Largest segment | Consumables |
Fastest growing segment | Consumables |
Historical data | 2016 - 2019 |
Base year | 2020 |
Forecast period | 2021 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | Consumables, Instruments, Software & Services |
Key market players worldwide | Diasorin SpA, Abbott Laboratories, Siemens Healthineers AG ADR, QuidelOrtho Corp, shenzhen mindray automation equipment co., Immunodiagnostic Systems, Beckman Coulter, Roche Holding AG ADR, Roche, Inova Diagnostics, Maccura |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to chemiluminescence immunoassay market will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 66.32% in 2020. Horizon Databook has segmented the Canada chemiluminescence immunoassay market based on consumables, instruments, software & services covering the revenue growth of each sub-segment from 2016 to 2028.
Increasing initiatives being undertaken by local players and growing market penetration of key players in Canada to fulfill the growing demand for CLIA products are among major factors propelling the market growth.
In May 2020, DiaSorin received Health Canada’s approval for its new LIAISON SARS-CoV-2 S1/S2 IgG test for the detection of Covid-19 in Canada. Furthermore, rising prevalence of chronic & infectious diseases and increasing healthcare expenditure in Canada are among factors anticipated to boost the market growth over the forecast period.
For instance, according to NCBI, in 2018, around 2,561 people in Canada were diagnosed with HIV, accounting for an increase of 8.2% from the previous year. Moreover, rise in the number of awareness programs is likely to drive the market.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada chemiluminescence immunoassay market , including forecasts for subscribers. This country databook contains high-level insights into Canada chemiluminescence immunoassay market from 2016 to 2028, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account